7MM treatment-resistant hypertension market to grow 5% annually until 2034 | Healthcare Asia Magazine
, Australia
Photo from Envato

7MM treatment-resistant hypertension market to grow 5% annually until 2034

Better diagnostic practices and combination therapy developments drive the sector.

The treatment-resistant hypertension (TRH) market across the seven major markets (7MM) is expected to expand at a compound annual growth rate of 5% from 2020 to 2034, according to a DelveInsight report.

The sector’s growth is attributed to the rising prevalence of uncontrolled hypertension and associated cardiovascular risks.

Moreover, better diagnostic practices, developments in combination therapies, and device-based interventions are driving market expansion.

“Advances in pharmaceuticals and procedures, along with innovations in pharmacogenomics, precision medicine, and digital health platforms, are expanding the landscape of treatment options for TRH,” the report said.

7MM = US, France, Germany, Italy, Spain, UK, and Japan

Follow the link for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!